annual cash & cash equivalents:
$453.00M+$141.34M(+45.35%)Summary
- As of today (July 1, 2025), HRMY annual cash & cash equivalents is $453.00 million, with the most recent change of +$141.34 million (+45.35%) on December 31, 2024.
- During the last 3 years, HRMY annual cash & cash equivalents has risen by +$218.69 million (+93.33%).
- HRMY annual cash & cash equivalents is now at all-time high.
Performance
HRMY Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$489.00M+$36.00M(+7.95%)Summary
- As of today (July 1, 2025), HRMY quarterly cash & cash equivalents is $489.00 million, with the most recent change of +$36.00 million (+7.95%) on March 31, 2025.
- Over the past year, HRMY quarterly cash & cash equivalents has increased by +$156.02 million (+46.85%).
- HRMY quarterly cash & cash equivalents is now at all-time high.
Performance
HRMY quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
HRMY Cash and cash equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +45.4% | +46.9% |
3 y3 years | +93.3% | +117.8% |
5 y5 years | +1752.2% | +583.8% |
HRMY Cash and cash equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +93.3% | at high | +106.7% |
5 y | 5-year | at high | +1752.2% | at high | +541.1% |
alltime | all time | at high | +1752.2% | at high | +1899.4% |
HRMY Cash and cash equivalents History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $489.00M(+7.9%) |
Dec 2024 | $453.00M(+45.4%) | $453.00M(+16.9%) |
Sep 2024 | - | $387.37M(+22.1%) |
Jun 2024 | - | $317.30M(-4.7%) |
Mar 2024 | - | $332.98M(+6.8%) |
Dec 2023 | $311.66M(+27.8%) | $311.66M(-4.0%) |
Sep 2023 | - | $324.60M(+2.3%) |
Jun 2023 | - | $317.42M(+10.2%) |
Mar 2023 | - | $287.96M(+18.1%) |
Dec 2022 | $243.78M | $243.78M(-6.7%) |
Sep 2022 | - | $261.34M(+10.5%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $236.53M(+5.4%) |
Mar 2022 | - | $224.50M(-4.2%) |
Dec 2021 | $234.31M(+2.5%) | $234.31M(+23.5%) |
Sep 2021 | - | $189.70M(+18.8%) |
Jun 2021 | - | $159.69M(+13.1%) |
Mar 2021 | - | $141.17M(-38.3%) |
Dec 2020 | $228.63M(+834.8%) | $228.63M(+3.1%) |
Sep 2020 | - | $221.74M(+190.7%) |
Jun 2020 | - | $76.28M(+6.7%) |
Mar 2020 | - | $71.52M(+192.4%) |
Dec 2019 | $24.46M(-70.7%) | $24.46M |
Dec 2018 | $83.52M | - |
FAQ
- What is Harmony Biosciences Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual cash & cash equivalents year-on-year change?
- What is Harmony Biosciences Holdings quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly cash & cash equivalents year-on-year change?
What is Harmony Biosciences Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of HRMY is $453.00M
What is the all time high annual cash & cash equivalents for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual cash & cash equivalents is $453.00M
What is Harmony Biosciences Holdings annual cash & cash equivalents year-on-year change?
Over the past year, HRMY annual cash & cash equivalents has changed by +$141.34M (+45.35%)
What is Harmony Biosciences Holdings quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of HRMY is $489.00M
What is the all time high quarterly cash & cash equivalents for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly cash & cash equivalents is $489.00M
What is Harmony Biosciences Holdings quarterly cash & cash equivalents year-on-year change?
Over the past year, HRMY quarterly cash & cash equivalents has changed by +$156.02M (+46.85%)